The HemOnc Pulse
Exploring treatment sequencing, prior therapy impact, and targeted approaches in lower-risk myelodysplastic syndromes.
A group of experts led by Naval Daver, MD discuss mutation loss, MRD dynamics, and transplant timing in evolving AML care.
Experts spotlight promising new CAR T-cell and bispecific therapies shaping the future of myeloma treatment.
Explore expert insights on bispecifics, CAR T-cell therapy, and emerging regimens for B-cell lymphomas.
Dr. Alexey Danilov discusses new therapies and ongoing challenges in the evolving CLL treatment landscape.
Experts discuss quadruplet therapy, MRD, and evolving transplant decisions in newly diagnosed multiple myeloma.
Dr. Amir Fathi discusses oral regimens and future AML therapy trends in this Editor’s Special of The HemOnc Pulse.
Experts explore CAR T therapy challenges and the future of lymphoma care beyond CD19-targeted treatments.
Experts discuss early detection in myeloid malignancies, from current challenges to future innovations.
At The HemOnc Pulse Live!, experts debate key controversies in MDS care, from frontline therapy to emerging treatments.
Gurbakhash Kaur, MD joins the host of The HemOnc Pulse Live! for a comprehensive discussion about the RedirecT-1 trial.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.